<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Idiopathic intracranial hypertension treatment overview</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Idiopathic intracranial hypertension treatment overview</h1>
<div class="graphic"><div class="figure"><div class="ttl">Idiopathic intracranial hypertension treatment overview</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Refer to UpToDate topic on the treatment of idiopathic intracranial hypertension for additional details regarding monitoring and treatment.</div><div class="graphic_footnotes">* Severe/fulminant disease is identified in patients with rapid progression of symptoms, severe papilledema (grade 3 or worse), substantial visual field and/or visual acuity loss, and/or more than 30 transient visual obscurations per month.<br/>¶ Patients without vision loss may be monitored closely or started on acetazolamide depending on risk factors and severity of papilledema.<br/>Δ Acetazolamide adult initial dosing is 500 mg orally twice daily advancing as required up to 2 to 4 grams per day in 2 to 3 divided doses, as tolerated. In young children, initial dosing is 25 mg/kg per day in 2 to 3 divided doses; adjust as needed and tolerated to a maximum of 100 mg/kg or 2 grams per day, whichever is less. Refer to UpToDate topic on the treatment of idiopathic intracranial hypertension for other details of medication dosing.<br/>◊ Patients with rapidly deteriorating vision may receive temporizing treatments such as lumbar drain if other intervention is delayed. Venous shunting may be an alternative to shunt or optic nerve sheath fenestration.</div><div id="graphicVersion">Graphic 133278 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
